Aetna Inc. (NYSE:AET) Stake Held by Nadler Financial Group Inc.

Nadler Financial Group Inc. continued to hold its position in shares of Aetna Inc. (NYSE:AET) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 7,884 shares of the company’s stock at the end of the second quarter. Aetna makes up about 0.4% of Nadler Financial Group Inc.’s portfolio, making the stock its 25th largest position. Nadler Financial Group Inc.’s holdings in Aetna were worth $1,197,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of AET. Guardian Life Insurance Co. of America boosted its position in shares of Aetna by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 1,353 shares of the company’s stock worth $173,000 after buying an additional 9 shares in the last quarter. Concert Wealth Management Inc. boosted its position in shares of Aetna by 0.4% in the first quarter. Concert Wealth Management Inc. now owns 3,262 shares of the company’s stock worth $405,000 after buying an additional 14 shares in the last quarter. CAPROCK Group Inc. boosted its position in shares of Aetna by 0.9% in the first quarter. CAPROCK Group Inc. now owns 2,824 shares of the company’s stock worth $360,000 after buying an additional 25 shares in the last quarter. Rehmann Capital Advisory Group boosted its position in shares of Aetna by 1.1% in the first quarter. Rehmann Capital Advisory Group now owns 2,335 shares of the company’s stock worth $298,000 after buying an additional 25 shares in the last quarter. Finally, Geneva Advisors LLC boosted its position in shares of Aetna by 1.0% in the first quarter. Geneva Advisors LLC now owns 2,588 shares of the company’s stock worth $330,000 after buying an additional 25 shares in the last quarter. 91.80% of the stock is currently owned by hedge funds and other institutional investors.

Aetna Inc. (AET) opened at 155.29 on Friday. Aetna Inc. has a 52-week low of $104.59 and a 52-week high of $157.56. The firm has a 50-day moving average of $152.90 and a 200 day moving average of $136.75. The firm has a market cap of $51.51 billion, a price-to-earnings ratio of 47.36 and a beta of 0.54.

Aetna (NYSE:AET) last issued its quarterly earnings data on Tuesday, May 2nd. The company reported $2.71 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.36 by $0.35. Aetna had a net margin of 1.84% and a return on equity of 17.75%. The company had revenue of $15.17 billion during the quarter, compared to the consensus estimate of $15.39 billion. During the same quarter in the prior year, the firm earned $2.30 earnings per share. The firm’s revenue was down 3.4% compared to the same quarter last year. On average, equities research analysts forecast that Aetna Inc. will post $8.99 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Friday, July 28th. Stockholders of record on Thursday, July 13th were given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 1.29%. The ex-dividend date was Tuesday, July 11th. Aetna’s dividend payout ratio is 62.31%.

A number of equities analysts have issued reports on the stock. UBS AG reissued a “buy” rating and issued a $160.00 target price (up previously from $147.00) on shares of Aetna in a report on Wednesday, May 17th. Argus restated a “buy” rating and issued a $165.00 price target (up previously from $145.00) on shares of Aetna in a research note on Tuesday, May 30th. Credit Suisse Group restated a “buy” rating and issued a $155.00 price target on shares of Aetna in a research note on Wednesday, May 17th. Cleveland Research upgraded shares of Aetna from a “neutral” rating to a “buy” rating in a research note on Thursday, May 11th. Finally, ValuEngine upgraded shares of Aetna from a “hold” rating to a “buy” rating in a research note on Friday, June 2nd. Seven investment analysts have rated the stock with a hold rating and eighteen have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and an average target price of $152.84.

In other news, EVP Margaret M. Mccarthy sold 27,028 shares of the stock in a transaction on Wednesday, June 7th. The shares were sold at an average price of $149.23, for a total transaction of $4,033,388.44. Following the completion of the sale, the executive vice president now owns 33,563 shares of the company’s stock, valued at $5,008,606.49. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Chairman Mark T. Bertolini sold 103,547 shares of the stock in a transaction on Wednesday, May 17th. The stock was sold at an average price of $140.79, for a total transaction of $14,578,382.13. Following the sale, the chairman now directly owns 659,888 shares of the company’s stock, valued at approximately $92,905,631.52. The disclosure for this sale can be found here. 0.90% of the stock is owned by corporate insiders.

About Aetna

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).